Akso Health Group (AHG) DCF Valuation
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Akso Health Group (AHG) Bundle
Designed for accuracy, our (AHG) DCF Calculator enables you to evaluate Akso Health Group's valuation using real-world financial data, offering complete flexibility to modify all essential parameters for improved projections.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11.4 | 1.8 | 6.3 | 13.2 | 2.4 | 2.6 | 2.8 | 3.1 | 3.3 | 3.6 |
| Revenue Growth, % | 0 | -84.65 | 259.62 | 108.86 | -81.68 | 8.42 | 8.42 | 8.42 | 8.42 | 8.42 |
| EBITDA | -18.8 | -2.1 | -3.3 | -14.2 | -8.5 | -2.4 | -2.6 | -2.8 | -3.0 | -3.3 |
| EBITDA, % | -164.37 | -118.04 | -51.66 | -108.09 | -352.06 | -90.33 | -90.33 | -90.33 | -90.33 | -90.33 |
| Depreciation | .1 | .0 | .0 | .0 | .1 | .0 | .0 | .0 | .1 | .1 |
| Depreciation, % | 1.05 | 0.86391 | 0.29139 | 0.13951 | 5.73 | 1.61 | 1.61 | 1.61 | 1.61 | 1.61 |
| EBIT | -18.9 | -2.1 | -3.3 | -14.3 | -8.6 | -2.4 | -2.6 | -2.8 | -3.0 | -3.3 |
| EBIT, % | -165.42 | -118.9 | -51.95 | -108.23 | -357.78 | -90.39 | -90.39 | -90.39 | -90.39 | -90.39 |
| Total Cash | 10.9 | 15.1 | 21.9 | 7.9 | 85.2 | 2.4 | 2.6 | 2.8 | 3.0 | 3.3 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 31.9 | 10.4 | 20.0 | 7.7 | .0 | 1.9 | 2.0 | 2.2 | 2.4 | 2.6 |
| Account Receivables, % | 278.95 | 594.91 | 316.9 | 58.39 | 0 | 71.68 | 71.68 | 71.68 | 71.68 | 71.68 |
| Inventories | -38,996.2 | -14.4 | 7.8 | 1.7 | .2 | -.4 | -.5 | -.5 | -.5 | -.6 |
| Inventories, % | -341023.32 | -818.98 | 123.53 | 12.79 | 7.92 | -15.86 | -15.86 | -15.86 | -15.86 | -15.86 |
| Accounts Payable | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditure | -.3 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | -2.75 | 0 | -0.07702312 | 0 | 0 | -0.5655 | -0.5655 | -0.5655 | -0.5655 | -0.5655 |
| Tax Rate, % | -4.04 | -4.04 | -4.04 | -4.04 | -4.04 | -4.04 | -4.04 | -4.04 | -4.04 | -4.04 |
| EBITAT | -20.1 | -2.1 | -3.3 | -14.3 | -9.0 | -2.4 | -2.6 | -2.8 | -3.0 | -3.3 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | 38,944.0 | -38,962.5 | -35.0 | 4.1 | .3 | -3.6 | -2.7 | -2.9 | -3.1 | -3.4 |
| WACC, % | 5.36 | 5.36 | 5.36 | 5.36 | 5.36 | 5.36 | 5.36 | 5.36 | 5.36 | 5.36 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -13.4 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -3 | |||||||||
| Terminal Value | -103 | |||||||||
| Present Terminal Value | -79 | |||||||||
| Enterprise Value | -93 | |||||||||
| Net Debt | -85 | |||||||||
| Equity Value | -7 | |||||||||
| Diluted Shares Outstanding, MM | 47 | |||||||||
| Equity Value Per Share | -0.16 |
What You Will Get
- Editable Forecast Inputs: Effortlessly modify key assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: Akso Health Group’s financial data pre-loaded to kickstart your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
- Customizable and Professional: A sleek Excel model tailored to meet your valuation requirements.
- Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.
Key Features
- 🔍 Real-Life AHG Financials: Pre-filled historical and projected data for Akso Health Group (AHG).
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Akso’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Akso’s valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Step 1: Download the prebuilt Excel template with Akso Health Group’s (AHG) data included.
- Step 2: Explore the pre-filled sheets and familiarize yourself with the key metrics.
- Step 3: Update forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly view recalculated results, including Akso Health Group’s (AHG) intrinsic value.
- Step 5: Make informed investment decisions or generate reports using the outputs.
Why Choose This Calculator for Akso Health Group (AHG)?
- Accurate Data: Up-to-date Akso Health Group financials provide trustworthy valuation outcomes.
- Customizable: Tailor essential parameters like growth rates, WACC, and tax rates to align with your forecasts.
- Time-Saving: Pre-configured calculations save you the hassle of starting from the ground up.
- Professional-Grade Tool: Crafted for investors, analysts, and consultants in the healthcare sector.
- User-Friendly: Easy-to-navigate design and clear instructions cater to users of all experience levels.
Who Should Use This Product?
- Healthcare Investors: Develop comprehensive and accurate valuation models for investment analysis in the health sector.
- Corporate Strategy Teams: Evaluate valuation scenarios to inform strategic decisions within healthcare organizations.
- Consultants and Advisors: Deliver precise valuation insights for Akso Health Group (AHG) to clients seeking healthcare investments.
- Students and Educators: Utilize real-world healthcare data to practice and instruct on financial modeling techniques.
- Health Industry Enthusiasts: Gain insights into the valuation processes of companies like Akso Health Group (AHG) in the market.
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled Akso Health Group (AHG) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for Akso Health Group (AHG).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.